Candesartan
CAS No. 139481-59-7
Candesartan( Candesartan, CV11974, CV-1197, CV 11974 )
Catalog No. M11648 CAS No. 139481-59-7
An angiotensin II receptor antagonist used mainly for the treatment of hypertension.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 48 | In Stock |
|
| 5MG | 37 | In Stock |
|
| 10MG | 51 | In Stock |
|
| 25MG | 112 | In Stock |
|
| 50MG | 165 | In Stock |
|
| 100MG | 244 | In Stock |
|
| 200MG | 361 | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameCandesartan
-
NoteResearch use only, not for human use.
-
Brief DescriptionAn angiotensin II receptor antagonist used mainly for the treatment of hypertension.
-
DescriptionAn angiotensin II receptor antagonist used mainly for the treatment of hypertension.Hypertension Approved(In Vivo):Candesartan (i.p.; 1 mg/kg/day; continuously for 1, 3 or 28 dpi) has neuroprotective effect, reducing neuronal injury, decreasing lesion volume and microglial activation, protecting CBF and improving functional behavior in a mouse model of TBI.
-
In Vitro——
-
In VivoAnimal Model:C57BL/6 mice (nine-week-old, male, 22–28?g)Dosage:1?mg/kgAdministration:i.p.; 1?mg/kg/day; continuously for 1, 3 or 28 dpi.Result:Reduced the lesion volume after CCI injury by approximately 50%, decreased the number of dying neurons, lessened the number of activated microglial cells, protected cerebral blood flow (CBF), and reduced the expression of the cytokine TGF?1 while increasing expression of TGFB3.Showed good motor skills on the rotarod 3 days after injury, and improved performance in the Morris water maze 4 weeks after injury.
-
SynonymsCandesartan, CV11974, CV-1197, CV 11974
-
PathwayGPCR/G Protein
-
TargetAngiotensin Receptor
-
RecptorAT1receptor
-
Research AreaCardiovascular Disease
-
IndicationHypertension
Chemical Information
-
CAS Number139481-59-7
-
Formula Weight440.45
-
Molecular FormulaC24H20N6O3
-
Purity>98% (HPLC)
-
SolubilityDMSO: 4.5 mg/mL (100 mM); Ethanol: 0.4 mg/mL (10 mM), with gentle warming ( < 1 mg/ml refers to the product slightly soluble or insoluble )
-
SMILESO=C(C1=C2N(CC3=CC=C(C4=CC=CC=C4C5=NNN=N5)C=C3)C(OCC)=NC2=CC=C1)O
-
Chemical Name2-Ethoxy-1-[[2'-(1H-tetrazol-5-yl)-1,1'-biphenyl-4-yl]methyl]-7-benzimidazolecarboxylic acid
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
Sparsentan
Sparsentan (RE-021) is a highly potent dual angiotensin II and endothelin A receptor antagonist with Kis of 0.8 and 9.3 nM, respectively.
-
Azilsartan
A specific and potent angiotensin II type 1 receptor (AT1) antagonist with IC50 of 2.6 nM.
-
Norleual
Angiotensin IV analog. Highly potent HGF/c-MET inhibitor (IC50 = 3 pM). Inhibits HGF-induced MDCK cell proliferation and invasion in vitro. Also AT4 receptor antagonist; disrupts LTP stabilization. Antiangiogenic.
Cart
sales@molnova.com